ABBOTT XIENCE V EVEROLIMUS ELUTING CORONARY STENT 1009542-15

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2009-05-08 for ABBOTT XIENCE V EVEROLIMUS ELUTING CORONARY STENT 1009542-15 manufactured by Abbott Vascular.

Event Text Entries

[19685036] The patient was enrolled in the (b)(4) study. During the procedure to place the xience v stent in coronary artery, the patient experienced dyspnea, erythema, and shaking. The physician felt that this was due to the iv contrast that was used during the procedure. The patient was not known to have an iv contrast allergy prior to the procedure. Contrast used optiray 320. Manufacturer mallinckrodt inc. , (b)(4). Dose or amount: 3. 5 mm x 15 mm, 100 ml. Frequency: once. Route: #1 and #2 - intracardiac. Dates of use: (b)(6)2008. Diagnosis or reason for use: cad. Event abated after use stopped or dose reduced: yes.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5011048
MDR Report Key1379594
Date Received2009-05-08
Date of Report2009-05-08
Date of Event2008-11-07
Date Added to Maude2010-10-26
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Sequence Number: 1

Brand NameABBOTT XIENCE V EVEROLIMUS ELUTING CORONARY STENT
Generic NameXIENCE
Product CodeNIQ
Date Received2009-05-08
Model Number1009542-15
Lot Number7110641
Device Expiration Date2008-11-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Sequence No1
Device Event Key0
ManufacturerABBOTT VASCULAR
Manufacturer AddressSANTA CLARA CA 95054280 US 95054 2807

Device Sequence Number: 2

Brand NameOPTIRAY 320
Generic NameIOVERSOL INJECTION 68%
Product CodeKTA
Date Received2009-05-08
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Sequence No2
Device Event Key0
ManufacturerTYCO HEALTHCARE/MALLINCK


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2009-05-08

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.